Haverford Trust Co. raised its stake in shares of CVS Health Corp (NYSE:CVS) by 41.4% during the 3rd quarter, Holdings Channel reports. The institutional investor owned 2,231,574 shares of the pharmacy operator’s stock after buying an additional 652,905 shares during the period. CVS Health comprises approximately 2.5% of Haverford Trust Co.’s holdings, making the stock its 12th largest position. Haverford Trust Co.’s holdings in CVS Health were worth $140,745,000 as of its most recent SEC filing.
A number of other institutional investors also recently added to or reduced their stakes in CVS. 1 North Wealth Services LLC acquired a new stake in shares of CVS Health during the third quarter worth approximately $29,000. Centaurus Financial Inc. boosted its holdings in shares of CVS Health by 570.8% during the first quarter. Centaurus Financial Inc. now owns 1,630 shares of the pharmacy operator’s stock worth $30,000 after purchasing an additional 1,387 shares during the period. Manchester Financial Inc. acquired a new stake in shares of CVS Health during the second quarter worth approximately $31,000. Hudock Capital Group LLC boosted its holdings in shares of CVS Health by 54.0% during the second quarter. Hudock Capital Group LLC now owns 576 shares of the pharmacy operator’s stock worth $31,000 after purchasing an additional 202 shares during the period. Finally, Executive Wealth Management LLC boosted its holdings in shares of CVS Health by 62.4% during the second quarter. Executive Wealth Management LLC now owns 565 shares of the pharmacy operator’s stock worth $31,000 after purchasing an additional 217 shares during the period. 76.17% of the stock is currently owned by hedge funds and other institutional investors.
In other CVS Health news, EVP Troyen A. Brennan sold 23,604 shares of CVS Health stock in a transaction on Monday, November 4th. The shares were sold at an average price of $68.00, for a total transaction of $1,605,072.00. Following the sale, the executive vice president now owns 107,921 shares in the company, valued at $7,338,628. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Joshua Matthew Flum sold 17,703 shares of CVS Health stock in a transaction on Monday, September 30th. The stock was sold at an average price of $63.00, for a total transaction of $1,115,289.00. Following the sale, the executive vice president now owns 36,163 shares in the company, valued at approximately $2,278,269. The disclosure for this sale can be found here. Insiders have sold 49,437 shares of company stock worth $3,248,811 in the last quarter. Corporate insiders own 0.53% of the company’s stock.
CVS stock traded up $0.69 on Friday, reaching $72.47. 9,243,125 shares of the company were exchanged, compared to its average volume of 6,966,567. CVS Health Corp has a 12 month low of $51.72 and a 12 month high of $82.15. The stock’s fifty day moving average price is $64.49 and its 200 day moving average price is $58.44. The firm has a market capitalization of $87.55 billion, a PE ratio of 10.24, a PEG ratio of 1.46 and a beta of 0.86. The company has a debt-to-equity ratio of 1.39, a current ratio of 0.95 and a quick ratio of 0.64.
CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.84 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.77 by $0.07. CVS Health had a net margin of 1.91% and a return on equity of 16.15%. The firm had revenue of $64.81 billion for the quarter, compared to the consensus estimate of $62.99 billion. During the same quarter in the previous year, the company earned $1.73 earnings per share. The business’s revenue was up 36.5% compared to the same quarter last year. As a group, research analysts expect that CVS Health Corp will post 6.99 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which was paid on Monday, November 4th. Shareholders of record on Thursday, October 24th were paid a dividend of $0.50 per share. The ex-dividend date was Wednesday, October 23rd. This represents a $2.00 dividend on an annualized basis and a yield of 2.76%. CVS Health’s dividend payout ratio is currently 28.25%.
Several research firms recently commented on CVS. ValuEngine upgraded shares of CVS Health from a “strong sell” rating to a “sell” rating in a report on Wednesday, October 2nd. Royal Bank of Canada began coverage on shares of CVS Health in a report on Friday, September 27th. They set an “outperform” rating and a $85.00 price target for the company. Raymond James raised their price target on shares of CVS Health from $75.00 to $80.00 and gave the stock a “strong-buy” rating in a report on Thursday. Barclays raised their price target on shares of CVS Health from $75.00 to $79.00 and gave the stock an “overweight” rating in a report on Thursday. Finally, SunTrust Banks raised their price target on shares of CVS Health to $85.00 and gave the stock a “buy” rating in a report on Thursday. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating, eighteen have assigned a buy rating and one has assigned a strong buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $78.17.
CVS Health Company Profile
CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.
Recommended Story: What is basic economics?
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.